Date published: 2026-5-16

1-800-457-3801

SCBT Portrait Logo
Seach Input

7,7-Dimethyleicosadienoic Acid (DEDA) (CAS 89560-01-0)

0.0(0)
Write a reviewAsk a question

Application:
7,7-Dimethyleicosadienoic Acid (DEDA) is an inhibitor of PLA2, sPLA2, and 5-LO
CAS Number:
89560-01-0
Purity:
98%
Molecular Weight:
336.6
Molecular Formula:
C22H40O2
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

7,7-Dimethyleicosadienoic Acid (DEDA) is an arachidonic acid analog that inhibits PLA2 (phospholipase A2). 7,7-Dimethyleicosadienoic Acid (DEDA) is reported to inhibit SRS-A biosynthesis occurring in peritoneal cells. This compound has been found to also inhibit P388D1 cell PLA2 and snake venom PLA2. DEDA may act to selectively inhibit human recombinant sPLA2 over cPLA2. This compound also weakly inhibits 5-LO (5-lipoxygenase).


7,7-Dimethyleicosadienoic Acid (DEDA) (CAS 89560-01-0) References

  1. Hyposmotically induced amino acid release from the rat cerebral cortex: role of phospholipases and protein kinases.  |  Estevez, AY., et al. 1999. Brain Res. 844: 1-9. PMID: 10536255
  2. The signal transduction of endothelin-1-induced circular smooth muscle cell contraction in cat esophagus.  |  Shin, CY., et al. 2002. J Pharmacol Exp Ther. 302: 924-34. PMID: 12183648
  3. Effect of the phospholipase A2 inhibitors quinacrine and 7,7-dimethyleicosadienoic acid in isolated globally ischemic rat hearts.  |  Sargent, CA., et al. 1992. J Pharmacol Exp Ther. 262: 1161-7. PMID: 1382129
  4. Interfacial catalysis by phospholipase A2: dissociation constants for calcium, substrate, products, and competitive inhibitors.  |  Jain, MK., et al. 1991. Biochemistry. 30: 7306-17. PMID: 1854739
  5. Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat.  |  Hoda, MN., et al. 2009. J Neuroinflammation. 6: 21. PMID: 19678934
  6. Role of endogenous psychosine accumulation in oligodendrocyte differentiation and survival: implication for Krabbe disease.  |  Won, JS., et al. 2013. Brain Res. 1508: 44-52. PMID: 23438514
  7. Ro 22-3747: a new antiallergic agent for the treatment of immediate hypersensitivity diseases.  |  Welton, AF., et al. 1984. J Pharmacol Exp Ther. 228: 57-64. PMID: 6198511
  8. Analogs of arachidonic acid methylated at C-7 and C-10 as inhibitors of leukotriene biosynthesis.  |  Cohen, N., et al. 1984. Prostaglandins. 27: 553-62. PMID: 6427852
  9. Alpha adrenergic receptor subtypes involved in prostaglandin synthesis are coupled to Ca++ channels through a pertussis toxin-sensitive guanine nucleotide-binding protein.  |  Nebigil, C. and Malik, KU. 1993. J Pharmacol Exp Ther. 266: 1113-24. PMID: 7689101
  10. Secretory phospholipase A2 inhibitors and calmodulin antagonists as inhibitors of cytosolic phospholipase A2.  |  Hope, WC., et al. 1993. Agents Actions. 39 Spec No: C39-42. PMID: 8273580
  11. Mechanisms of glutamate and aspartate release in the ischemic rat cerebral cortex.  |  Phillis, JW. and O'Regan, MH. 1996. Brain Res. 730: 150-64. PMID: 8883899
  12. Low-density lipoprotein stimulated peroxide production and endocytosis in cultured human endothelial cells: mechanisms of action.  |  Holland, JA., et al. 1997. Endothelium. 5: 191-207. PMID: 9272382
  13. Amino acid release during volume regulation by cardiac cells: cellular mechanisms.  |  Song, D., et al. 1998. Eur J Pharmacol. 341: 273-80. PMID: 9543249

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

7,7-Dimethyleicosadienoic Acid (DEDA), 10 mg

sc-200707
10 mg
$99.00

7,7-Dimethyleicosadienoic Acid (DEDA), 50 mg

sc-200707A
50 mg
$364.00